Skip to main content
. 2022 Jun 16;16:1414. doi: 10.3332/ecancer.2022.1414

Table 4. Responses in patients receiving intrathecal therapy.

Response Number of patients Intrathecal therapy (Number of patients)
Complete response 1 Intrathecal methotrexate (1)
Partial response 2 Intrathecal therapy (2)
Triple intrathecal therapy (1)
Intrathecal methotrexate (1)
Stable disease 11 Intrathecal therapy (6)
Triple intrathecal therapy (2)
Intrathecal methotrexate (4)
No intrathecal therapy (5)
Progressive disease 17 Intrathecal therapy (2)
Triple intrathecal therapy (0)
Intrathecal methotrexate (2)
No intrathecal therapy (15)